Success Stories: An Indian Clinical Research Fellow in Transplant Endocrinology Wins NIW Approval in Less Than 4 Months, Thanks to Our Team’s Help

 

Client’s Testimonial:

“Thank you again for all your efficient work. I am extremely delighted to hear the news about the approval of my I-140 NIW. I can't thank you enough for all the excellent work you have done. Thanks again for all your assistance.”

---

On February 3^rd, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Clinical Research Fellow in the Field of Transplant Endocrinology (Approval Notice).

---

General Field: Transplant Endocrinology

Position at the Time of Case Filing: Clinical Research Fellow

Country of Origin: India

State of Residence at the Time of Filing: Minnesota

Approval Notice Date: February 3^rd, 2023

Processing Time: 3 months, 22 days

---

Case Summary:

When a clinical research fellow in transplant endocrinology from India came to NAILG for his NIW or National Interest Waiver petition, our team first tried to ascertain if his credentials were the right fit for the NIW category. Once this was done, we moved forward to sign the retainer with him. Our team knew the strong points of his career and worked to incorporate them into the petition, which was thus personalized for our client. Once the filing was over, we had to wait for a short period of 3 months and 22 days before the approval came through.

Some of the key factors that played a role in the approval were as follows:

• His proposed endeavor was to continue his research on endocrine-related metabolic conditions in solid organ and cellular transplant recipients to understand the pathophysiology of these metabolic complications and evaluate post-transplant outcomes.
• His proposed endeavor is of great importance because it contributes to the development of new methods, techniques, and strategies for improving disease treatment. His findings have established new parameters and frameworks for other researchers in the field of transplant endocrinology while also improving the real-world application of clinical research for patients suffering from these diseases.
• His ongoing work in the field of transplant endocrinology is therefore highly relevant to global efforts to reduce the impact of chronic disease.
• His proposed endeavor also has broad implications for the United States, since his ongoing research in the field of transplant endocrinology has proven highly valuable for the interests of the United States, particularly in terms of using advanced methods to enhance islet cell transplantation and other avenues for treating diseases such as chronic pancreatitis and diabetes. These and other metabolic conditions have an outsized effect on public health and well-being throughout the United States.
• His research has resulted in 9 peer-reviewed journal articles (5 of them first-authored) published in well-known journals in the field.
• At the same time, these publications have been cited a total of 80 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of transplant endocrinology.
• We also added detailed descriptions of 4 of his key projects have been included as evidence of his contributions to and expertise in the field of transplant endocrinology.
• Finally, we attached 2 letters of recommendation written by other experts who knew his work and supported it.

So, his 5 years of research in the field indeed aided him in getting the approval as quickly as possible. His experience played in his favor and won the NIW case without an RFE. We are proud of having worked with him and we wish him the best in his future endeavors.

---